Abstracts tagged "imaging techniques and tocilizumab"

Abstract Number: 2748 • 2018 ACR/ARHP Annual Meeting
Giant Cell Arteritis in Treatment with Tocilizumab. Evolution of Vascular FDG Uptake on PET/CT
Diana Prieto Peña¹, Javier Loricera², Monica Calderón Goercke¹, Francisco Javier Narváez³, Elena Aurrecoechea⁴, Ignacio Villa-Blanco⁵, Santos Castañeda⁶, Catalina Gómez-Arango⁷, Noelia Álvarez-Rivas⁸, Antonio Mera⁹, Eva Perez Pampín⁹, Vicente Aldasoro¹⁰, Nagore Fernandez-Llanio Cornella¹¹, Maria Concepcion Alvarez de Buergo¹², Luisa Marena Rojas Vargas¹³, Francisca Sivera¹⁴, Eva Galindez-Agirregoikoa¹⁵, Roser Solans¹⁶, Susana Romero-Yuste¹⁷, Belén Atienza-Mateo¹⁸, José Luis Martín-Varillas¹⁸, Isabel Martínez-Rodríguez¹⁹, Ignacio Banzo¹⁹, Vanesa Calvo-Río¹⁸, Natalia Palmou-Fontana¹⁸, José Luis Hernández², Miguel Angel González-Gay¹⁸ and Ricardo Blanco¹⁸, ¹Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, ⁴Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ⁵Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ⁶Rheumatology, Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain, ⁷Hospital Alto Deba, Mondragón. Spain, Mondragón, Spain, ⁸Hospital Universitario Lucus Augusti, Lugo. Spain, Lugo, Spain, ⁹Rheumatology Division. Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, ¹⁰Hospital Alto Deba. Mondragón. Spain, Mondragon, Spain, ¹¹Rheumatology Section. Hospital Arnau de Vilanova, Valencia, Spain, ¹²Rheumatology, Hospital Río Carrión. Palencia. Spain, Palencia, Spain, ¹³Rheumatology Department, Hospital General La Mancha Centro, Alcázar de San Juan, Spain, ¹⁴Rheumatology, Hospital General Universitario de Elda. Comunidad Valenciana. Spain, Elda, Spain, ¹⁵Rheumatology Division, Hospital Universitario de Basurto, Bilbao, Spain, ¹⁶Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, ¹⁷Hospital de Pontevedra. Spain, Pontevedra, Spain, ¹⁸Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ¹⁹Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Giant cell arteritis (GCA) is a large-vessel vasculitis which can involve the aorta and/or its major branches. Tocilizumab (TCZ) seems to be effective in…
Abstract Number: 2753 • 2018 ACR/ARHP Annual Meeting
Extension of Extracranial Vessel Involvement in Patients with Giant Cell Arteritis
Monica Calderón Goercke¹, Javier Loricera², Diana Prieto Peña¹, Francisco Javier Narváez³, Elena Aurrecoechea⁴, Ignacio Villa-Blanco⁵, Santos Castañeda⁶, Catalina Gómez-Arango⁷, Antonio Mera⁸, Eva Perez Pampín⁸, Vicente Aldasoro⁹, Noelia Álvarez-Rivas¹⁰, Nagore Fernandez-Llanio Cornella¹¹, Maria Concepcion Alvarez de Buergo¹², Luisa Marena Rojas Vargas¹³, Francisca Sivera¹⁴, Eva Galindez-Agirregoikoa¹⁵, Roser Solans¹⁶, Susana Romero-Yuste¹⁷, Norberto Ortego Centeno¹⁸, Marcelino Revenga Martínez¹⁹, Rafael Melero²⁰, Eva Salgado-Pérez²¹, Sabela Fernández²², José Luis Martín-Varillas²³, Isabel Martínez-Rodríguez²⁴, Ignacio Banzo²⁴, Vanesa Calvo-Río²³, Belén Atienza-Mateo²³, Natalia Palmou-Fontana²³, Carmen González-Vela²⁵, José Luis Hernández², Miguel Angel González-Gay²³ and Ricardo Blanco²³, ¹Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain, ⁴Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ⁵Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ⁶Rheumatology, Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain, ⁷Hospital Alto Deba, Mondragón. Spain, Mondragón, Spain, ⁸Rheumatology Division. Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, ⁹Hospital Alto Deba. Mondragón. Spain, Mondragon, Spain, ¹⁰Hospital Universitario Lucus Augusti, Lugo. Spain, Lugo, Spain, ¹¹Rheumatology Section. Hospital Arnau de Vilanova, Valencia, Spain, ¹²Rheumatology, Hospital Río Carrión. Palencia. Spain, Palencia, Spain, ¹³Rheumatology Department, Hospital General La Mancha Centro, Alcázar de San Juan, Spain, ¹⁴Rheumatology, Hospital General Universitario de Elda. Comunidad Valenciana. Spain, Elda, Spain, ¹⁵Rheumatology Division, Hospital Universitario de Basurto, Bilbao, Spain, ¹⁶Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, ¹⁷Hospital de Pontevedra. Spain, Pontevedra, Spain, ¹⁸Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ¹⁹Hospital Universitario Ramón y Cajal. Madrid. Spain, Madrid, Spain, ²⁰Rheumatology, Complexo Hospitalario Universitario de Vigo, Vigo. Spain, Vigo, Spain, ²¹Rheumatology, Complejo Hospitalario Universitario de Ourense, Ourense. Spain, Ourense, Spain, ²²Rheumatology, Hospital Universitario San Agustín, Avilés. Spain, Avilés, Spain, ²³Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²⁴Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²⁵Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Giant cell arteritis (GCA) is a large vessel vasculitis with a predisposition for the cranial branches of the external carotid artery. However, aorta and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].